0001209191-20-032291.txt : 20200527 0001209191-20-032291.hdr.sgml : 20200527 20200527161420 ACCESSION NUMBER: 0001209191-20-032291 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200526 FILED AS OF DATE: 20200527 DATE AS OF CHANGE: 20200527 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stejbach Mark CENTRAL INDEX KEY: 0001487937 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36287 FILM NUMBER: 20915370 MAIL ADDRESS: STREET 1: C/O TENGION, INC. STREET 2: 2900 POTSHOP LANE, SUITE 100 CITY: EAST NORRITON STATE: PA ZIP: 19403 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Flexion Therapeutics Inc CENTRAL INDEX KEY: 0001419600 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 MALL ROAD STREET 2: SUITE 301 CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: (781) 305-7777 MAIL ADDRESS: STREET 1: 10 MALL ROAD STREET 2: SUITE 301 CITY: BURLINGTON STATE: MA ZIP: 01803 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-05-26 0 0001419600 Flexion Therapeutics Inc FLXN 0001487937 Stejbach Mark C/O FLEXION THERAPEUTICS, INC. 10 MALL ROAD, SUITE 301 BURLINGTON MA 01803 1 0 0 0 Common Stock 2020-05-26 4 P 0 2051 9.75 A 2051 D Common Stock 1580 I By The Mark P. Stejbach Revocable Trust UA 07-08-2016 The shares were purchased in connection with the Issuer's public offering. /s/ Mark S. Levine, Attorney-in-Fact 2020-05-27